Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Zinn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Virology|August 17, 2014
Adeno-associated virus: fit to serveEric Zinn, Luk H Vandenberghe
Human Gene Therapy|January 13, 2018
Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In VivoLivia S Carvalho, Ru Xiao, Sarah J Wassmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 1, 2019
GPR108 Is a Highly Conserved AAV Entry FactorAmanda M Dudek, Nerea Zabaleta, Eric Zinn, et al.
Cell Reports|August 4, 2015
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy VectorEric Zinn, Simon Pacouret, Vadim Khaychuk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1FCole W Peters, Killian S Hanlon, Maryna V Ivanchenko, et al.
Molecular Therapy. Methods & Clinical Development|January 8, 2020
Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV LibrariesPauline F Schmit, Simon Pacouret, Eric Zinn, et al.
Cell Reports. Medicine|November 3, 2022
Ancestral library identifies conserved reprogrammable liver motif on AAV capsidEric Zinn, Carmen Unzu, Pauline F Schmit, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primatesNerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Cell Host & Microbe|August 24, 2021
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primatesNerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Virology|August 17, 2014
Adeno-associated virus: fit to serveEric Zinn, Luk H Vandenberghe
Human Gene Therapy|January 13, 2018
Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In VivoLivia S Carvalho, Ru Xiao, Sarah J Wassmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 1, 2019
GPR108 Is a Highly Conserved AAV Entry FactorAmanda M Dudek, Nerea Zabaleta, Eric Zinn, et al.
Cell Reports|August 4, 2015
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy VectorEric Zinn, Simon Pacouret, Vadim Khaychuk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1FCole W Peters, Killian S Hanlon, Maryna V Ivanchenko, et al.
Molecular Therapy. Methods & Clinical Development|January 8, 2020
Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV LibrariesPauline F Schmit, Simon Pacouret, Eric Zinn, et al.
Cell Reports. Medicine|November 3, 2022
Ancestral library identifies conserved reprogrammable liver motif on AAV capsidEric Zinn, Carmen Unzu, Pauline F Schmit, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primatesNerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Cell Host & Microbe|August 24, 2021
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primatesNerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Pageof 1